InnoCan Pharma Corporation
INNO
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -0.90% | -8.02% | 0.21% | 13.98% | 27.10% |
| Total Receivables | 37.82% | 19.95% | 7.81% | -32.72% | 102.43% |
| Inventory | -0.05% | -10.95% | -6.03% | -11.85% | -10.94% |
| Prepaid Expenses | 5.56% | 33.33% | 14.89% | -32.86% | 4.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.23% | 18.88% | 54.82% | 27.54% | 7.76% |
| Total Current Assets | 3.15% | -5.33% | 0.80% | 2.12% | 17.09% |
|
|
|||||
| Total Current Assets | 3.15% | -5.33% | 0.80% | 2.12% | 17.09% |
| Net Property, Plant & Equipment | -6.98% | -7.53% | -7.00% | -6.54% | -5.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.07% | -5.35% | 0.72% | 2.03% | 16.81% |
|
|
|||||
| Total Accounts Payable | 39.15% | 446.51% | -81.55% | 30.90% | -3.78% |
| Total Accrued Expenses | 8.17% | 22.54% | 0.00% | -15.99% | 49.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -57.14% | -30.00% |
| Total Finance Division Other Current Liabilities | -1.81% | -83.36% | 9.49% | 22.56% | 10.48% |
| Total Other Current Liabilities | -1.81% | -83.36% | 9.49% | 22.56% | 10.48% |
| Total Current Liabilities | 44.06% | -54.25% | 0.27% | 12.45% | 17.38% |
|
|
|||||
| Total Current Liabilities | 44.06% | -54.25% | 0.27% | 12.45% | 17.38% |
| Long-Term Debt | 3.87% | -38.94% | 9.25% | 7.07% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 27.70% | -49.05% | 3.15% | 10.66% | 75.56% |
|
|
|||||
| Common Stock & APIC | 1.38% | -0.60% | 3.96% | 0.29% | 0.24% |
| Retained Earnings | -2.70% | 5.25% | -5.40% | -1.66% | -1.67% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -7.07% | 45.28% | -8.37% | -10.13% | -9.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.07% | 45.28% | -8.37% | -10.13% | -9.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 3.26% | -5.04% | 11.88% | 12.45% | 19.03% |
| Total Equity | -3.76% | 24.20% | -0.85% | -2.89% | -1.91% |
|
|
|||||